Advanced Medical Iso (ADMD) 0.0049 $ADMD Are These

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Advanced Medical Iso (ADMD) 0.0049 $ADMD

Are These Trending Sub Penny Stocks On Your May Watchlist?
ACCESSWIRE - Tue May 12, 11:49AM CDT
CORAL GABLES, FL / ACCESSWIRE / May 12, 2015 / The Over The Counter Exchange or "OTC" has thousands of companies, many of which are in the very early stages of development. These stocks trade in all levels of price and when many think of "The OTC" they think penny stocks. The recent trend in 2015 has been focused on those stocks trading below a penny and "yes" they do exist. Companies focused on anything from medical devices to property management have found themselves on this exchange in hopes of raising capital through the public markets. Early this month companies like Hangover Joe's Holding Corp (PINKSHEETS: HJOE), Advanced Medical Isotope Corp. (PINKSHEETS: ADMD) and Enviro-Serv, Inc. (PINKSHEETS: EVSV) have all begun to see increases in volume and share price during the first half of May, 2015.

Advanced Medical Isotope Capital Restructuring Drives Shares Skywards - BrokerBank Securities, Inc.
PR Newswire - Mon May 04, 6:00AM CDT
Advanced Medical Isotope Corp. (OTCBB: ADMD) a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, recently announced the initiation of a capital restructuring plan in which $5 million of long term debt was converted into a newly designated series of equity based convertible preferred stock. ADMD believes that these actions will have a positive impact on the Company's balance sheet, potentially eliminating up to $800,000 of convertible debt, potentially eliminating a substantial portion of the warrants outstanding and potentially eliminating a substantial amount of the nearly $11 million of derivative liabilities currently reflected on AMIC's balance sheet.

Advanced Medical Isotope Corporation Provides Additional Update on Strategic Plan
ACCESSWIRE - Thu Apr 30, 2:45PM CDT
KENNEWICK, WA / ACCESSWIRE / April 30, 2015 / Advanced Medical Isotope Corporation ("AMIC" (PINKSHEETS: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today provided an update on additional matters that will significantly simplify AMIC's capital structure and improve its balance sheet.

Radiopharmaceuticals Market 2015: - Global Strategic Business Report
M2 - Thu Apr 30, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bld7rj/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc (US) - Advanced Medical Isotope Corporation (US) - Alliance Medical (UK) - Alseres Pharmaceuticals, Inc (US) - Avid Radiopharmaceuticals (US) - Bayer HealthCare Medical Care (US) - Bracco Diagnostics, Inc. (US) - Cardinal Health, Inc (US) - GE Healthcare (UK) - Ion Beam Applications S.A (Belgium) - Immunomedics, Inc. (US) - Jubilant Pharma (India) - Lantheus Medical Imaging Inc (US) - Mallinckrodt Pharmaceuticals (Ireland) - Medi-Radiopharma Ltd (Hungary) - Nordion, Inc. (Canada) - Peregrine Pharmaceuticals, Inc. (US) - PETNET Solutions Inc (US) - Positron Corporation (US) - Singapore Radiopharmaceuticals Pte Ltd (Singapore) - Triad Isotopes, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS & ISSUES 3. RADIO ISOTOPES MO-99/TC 99 SUPPLIES A REVIEW 4. THERAPEUTIC RADIOPHARMACEUTICAL PRODUCTS UNDER DEVELOPMENT 5. IMAGING AGENTS AN OVERVIEW 6. NUCLEAR MEDICINE AN OVERVIEW 7. PRODUCT OVERVIEW 8. PRODUCT INNOVATIONS/INTRODUCTIONS 9. RECENT INDUSTRY ACTIVITY 10. FOCUS ON SELECT PLAYERS 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 57 (including Divisions/Subsidiaries 64) - The United States (28) - Canada (2) - Japan (1) - Europe (22) - - France (2) - - Germany (3) - - The United Kingdom (3) - - Italy (2) - - Spain (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/bl...rmaceutica
IMMU: 4.12 (+0.05), ATNM: 2.59 (+0.08), CAH: 87.55 (-0.45)

Advanced Medical Isotope Corporation Initiates Capital Restructuring Plan
ACCESSWIRE - Thu Apr 23, 5:20AM CDT
KENNEWICK, WA / ACCESSWIRE / April 23, 2015 / Advanced Medical Isotope Corporation ("AMIC" (PINKSHEETS: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today provided information on completion of the initial steps of the Company's capital restructuring plan.

Penny Stocks Movers for Medican Enterprises, Advanced Medical Isotope, Radiant Creations Group, CIG Wireless, MRI Interventions, and NuGene
PR Newswire - Wed Mar 25, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Medican Enterprises (OTCMKTS:MDCN), Advanced Medical Isotope (OTCMKTS:ADMD), Radiant Creations Group (OTCBB:RCGP), CIG Wireless (OTCBB:CIGW), MRI Interventions (OTCBB:MRIC), and NuGene (OTCBB:NUGN).

Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device
PR Newswire - Tue Dec 23, 10:13AM CST
Advanced Medical Isotope Corporation ("AMIC" (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that it has filed a de novo submission with the Food and Drug Administration ("FDA" for marketing clearance for its patented Y-90 RadioGel(TM) device pursuant to Section 513(f)(2) of the U.S. Food, Drug and Cosmetic Act (the "Act" .

Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner
ACCESSWIRE - Fri Dec 19, 4:57PM CST
Kennewick, WA / ACCESSWIRE / December 19, 2014 / Advanced Medical Isotope Corporation ("AMIC" (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a Life Sciences Discovery Fund (LSDF) Proof of Concept Grant has been awarded for which AMIC is the commercialization partner. The award was made to Washington State University (WSU) for the proposal titled "Optimized Injectable Radiogels for High-dose Therapy of Non-resectable Solid Tumors," submitted by Principal Investigator Dr. Darrell Fisher, in the amount of $250,000. AMIC will receive a portion of the award by supplying product to WSU for the study as well as providing scientific and technical support. AMIC plans to use the data generated during the study to support the commercialization of the Company's brachytherapy products. Dr. Darrell Fisher serves on the AMIC Medical Advisory Board.

More Fallout From Stock Promotion Scandal
Richard Pearson - Seeking Alpha - Fri Nov 14, 1:35PM CST
Back in March, I highlighted the undisclosed paid stock promotions being run by the Dream Team Group in connection with CytRX (NASDAQ: CYTR ) and Galena (NASDAQ: GALE ). In the wake of that scandal, we have seen both of their stock prices plunge by...
CYTR: 4.11 (+0.03), LBIO: 10.60 (+0.50), GALE: 1.35 (-0.01)

Novel Drug Delivery System (NDDS) in Cancer Therapy Market - Global Industry Analysis to 2020 for the $15 Billion Market
M2 - Wed Nov 12, 3:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/ws3rns/ndds_in_cancer) has announced the addition of the "NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global market for NDDS in cancer therapy was valued at USD 3,655.3 million in 2013 and is expected to reach USD 15,984.2 million in 2020, growing at a CAGR of 23.7% during the forecast period from 2014 to 2020 The world is witnessing a continuous rise in the incidence of various types of cancer. Clinical benefits of embolic agents and nanoparticles over other therapy and drug delivery systems; technological advances leading to the development of new and innovative therapy; and expanding therapeutic indications of existing NDDS are some of the major factors expected to drive growth of the global NDDS in cancer therapy market during the forecast period from 2014 to 2020. On the other hand, factors such as high treatment cost associated with NDDS, strict regulatory pathways and cost associated with new product development may restrict market growth to some extent. One of the major opportunities in this market is nano-enabled drug delivery systems as this segment has been anticipated to grow at the highest CAGR of 24.7% during the forecast period. Embolization particles, liquid embolics and nanoparticles as drug delivery systems altogether comprise the global market for NDDS in cancer therapy. PVA particles, microspheres, drug eluting beads (DEB) and selective internal radiation therapy (SIRT) are the major products under the embolization particles market segment, while Onyx LES and TRUFILL nBCA LES are the two major liquid embolic system brands. The liquid embolics market segment is expected to grow at a CAGR of 4.9% during the forecast period from 2014 to 2020. Nanoparticles in novel drug delivery systems have emerged as a promising technology to treat patients suffering from various types of cancer. The market for nanoparticles segment was valued at USD 3,307.7 million in 2013 with the largest revenue share in the overall NDDS in cancer therapy market. Over the past two decades, many nanoparticles such as Doxil (doxorubicin), Megace ES (megestrol acetate), Abraxane (paclitaxel), Myocet (doxorubicin), DepoCyt (liposomal cytarabine), and DaunoXome (daunorubicin citrate) have been approved as drug delivery systems for cancer therapy. NDDS in Cancer Therapy Market, by Technology Embolization Particles Current Technologies - Drug Eluting Beads - Others (PVA particles, microspheres, gelatin-based) Emerging Technologies - Selective Internal Radiation Therapy (SIRT) - TheraSphere - SIR-Spheres - Holmium-based Microspheres Liquid Embolics - Onyx (LES and HD-500) - TRUFILL nBCA LES Nanoparticles Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Embolization Particles Market Revenue, by Type Chapter 5 Global Liquid Embolics Market Revenue, by Brand Chapter 6 Global Nanoparticles Market Revenue Chapter 7 Global NDDS in Cancer Therapy Market, by Geography Chapter 8 Recommendations Companies Mentioned - Advanced Medical Isotope Corporation - BTG plc - Bind Therapeutics - Boston Scientific Corporation - CeloNova BioSciences - Cook Medical - Cospheric LLC - Covidien - Eckert & Ziegler BEBIG - EmboMedics - Terumo Medical Corporation. - Kobo Products - Merit Medical Systems - Mo-Sci Corporation - Nanobiotix - Polysciences - Sirtex Medical For more information visit http://www.researchandmarkets.com/research/ws..._in_cancer
BSX: 17.85 (-0.06), MMSI: 20.64 (-0.10)

Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted
PR Newswire - Tue Sep 16, 11:02AM CDT
Advanced Medical Isotope Corporation ("AMIC" (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a patent was awarded for technology related to its brachytherapy products. AMIC's rights for the newly issued patent arise from its license from Battelle, under which AMIC exclusively licensed technologies developed at Pacific Northwest National Laboratory and the University of Utah for its proposed brachytherapy products. The patent awarded, US 8,821,364 B2, relates to AMIC's brachytherapy seed product and is entitled: Brachytherapy Seed with Fast Dissolving Matrix for Optimal Delivery of Radionuclides to Cancer Tissue. AMIC will support Battelle in further patent protection for additional markets consistent with AMIC's overall global commercialization strategy.

Battelle Acquires over 10% of Advanced Medical Isotope Corporation
PR Newswire - Mon Jul 07, 6:22AM CDT
Advanced Medical Isotope Corporation ("AMIC" (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock. Battelle is a leading international science and technology enterprise that explores emerging areas of science and develops and commercializes technology.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarivate's 2026 Research List Carries a Trust Test

Updated Category News Views 254

Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...

Continue Reading
PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 72

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 72

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 135

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 69

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 95

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 34

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 93

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 46

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
AutoMobility LA Puts 2028 Mobility on Center Stage

Updated Category News Views 38

Los Angeles is cramming an awful lot of automotive ambition into one Thursday. AutoMobility LA opens November 19 at the Los Angeles Convention Center, one day before the LA Auto Show begins its November 20–29 public run. Yes, there will be coffee carts, awards, creators and the usual event confetti. But beneath that polished show-floor racket sits a fairly serious...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Bond Fund Faces Investigation for Misconduct

Updated Category News Views 327

Investigation of Easterly ROCMuni High Income Bond Fund Investors of the Easterly ROCMuni High Income Municipal Bond Fund are facing troubling times. Recently, the Portnoy Law Firm initiated an investigation regarding potential securities fraud associated with this investment vehicle. If you have lost money after investing in the Easterly ROCMuni High Income, it's...

Continue Reading
Japan's Economic Transformation: Unleashing Investment Potential

Updated Category News Views 271

Understanding the Shift in Japanese Equities Japanese equities are experiencing a resurgence, and this transformation is hard to ignore. The landscape of investment in Japan is shifting rapidly, and for those keeping an eye on the developments, there are compelling reasons to be optimistic. For years, conventional thought had deemed Japan as a country facing overwhelming...

Continue Reading
Pet Grooming Services Market Growth Driven by Humanization Trends

Updated Category News Views 129

Exploring the Pet Grooming Services Market Growth The pet grooming services market is witnessing a remarkable transformation, with anticipated growth projected to reach over USD 12.05 billion during the next decade. The rising phenomenon of pet ownership, coupled with the ongoing trend of humanization, is significantly influencing this expansion. The global market was...

Continue Reading
Investors Unite Against Dow Inc. in Class Action Suit

Updated Category News Views 181

Class Action Lawsuit Filed Against Dow Inc. Pomerantz LLP has announced the filing of a significant class action lawsuit against Dow Inc. (NYSE: DOW) and certain high-ranking officials within the company. This legal move signals a definitive call to action for investors who may have been adversely affected by the company’s alleged misrepresentations and omissions...

Continue Reading
Innovative Philanthropy: A New Challenge for MrBeast

Updated Category News Views 505

Revolutionizing Philanthropy: A New Challenge for MrBeast In an exciting initiative that aims to transform the landscape of modern philanthropy, the 144K Collective has reached out to the well-known YouTube personality and philanthropy leader Jimmy Donaldson, popularly known as MrBeast. This event, titled "144K Vs. The Beast," represents a novel approach to enhancing...

Continue Reading